Abstract
It has been suggested that angiogenesis and angiogenic factors may be strong predictors of relapse in patients with breast carcinoma. We measured the levels of the angiogenic peptide basic fibroblast growth factor (bFGF) in 140 breast tumour cytosols using an immunoassay. There were no significant differences in bFGF levels between breast non-malignant lesions and primary carcinomas. In 124 cases with primary breast cancer, we observed an association of low bFGF levels (< 400 pg mg[-1]) with increasing tumour size (P = 0.023) and stage of disease (P = 0.002). bFGF levels did not correlate with other variables, including axillary nodes, hormone receptors, cathepsin D and the serum tumour markers CA15.3 and CEA. With a median follow-up of 44.0 months, breast cancer patients with low levels of bFGF had a significantly shorter disease-free survival (DFS) than patients with elevated bFGF (log-rank, P < 0.0001). In a multivariate analysis of DFS, only bFGF, T-stage and histological grade showed statistical significance. In a parallel evaluation of circulating bFGF, we did not observe a correlation between the serum and tissue bFGF levels in the 29 selected cases with matched determinations. Our results indicate that low bFGF levels in breast carcinoma are an independent prognostic indicator of poor prognosis and disease recurrence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colomer, R., Aparicio, J., Montero, S. et al. Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. Br J Cancer 76, 1215–1220 (1997). https://doi.org/10.1038/bjc.1997.536
Issue Date:
DOI: https://doi.org/10.1038/bjc.1997.536
This article is cited by
-
Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
British Journal of Cancer (2009)
-
Die Rolle von Tyrosinkinasen bei Krebserkrankungen des Kopf-Hals-Bereichs
HNO (2009)
-
Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance
Journal of Translational Medicine (2008)
-
Serum endostatin and bFGF as predictive factors in advanced breast cancer patients treated with letrozole
Clinical and Translational Oncology (2006)
-
Expression of Basic Fibroblast Growth Factor Correlates with Resistance to Paclitaxel in Human Patient Tumors
Pharmaceutical Research (2006)